Trident Toxicology — Form D
Trident Toxicology of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-02. The offering totals $200K, of which $25K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2014-10-02
- Form: D
- Accession: 0001621311-14-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $25K
- Remaining: $175K
- Minimum investment: $3K
- Investors: 7
- Date of first sale: 2014-05-16
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-225683
Issuer
- Name: Trident Toxicology
- CIK: 0001621311
- Entity type: Limited Liability Company
- Jurisdiction: TEXAS
- Incorporated: 2013
- Address: 5710 LBJ FREEWAY, DALLAS, TX, 75240
- Phone: 469-888-2258
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Josh James Daniel | Executive Officer | Dallas, TX |
Other filings by this issuer (1)
More